Department of Pathology, Immunology and Laboratory Medicine, University of Florida Diabetes Institute, Gainesville, Florida, USA.
Adaptive Biotechnologies Corporation, Seattle, Washington, USA.
JCI Insight. 2016 Dec 8;1(20):e88242. doi: 10.1172/jci.insight.88242.
The adaptive immune repertoire plays a critical role in type 1 diabetes (T1D) pathogenesis. However, efforts to characterize B cell and T cell receptor (TCR) profiles in T1D subjects have been largely limited to peripheral blood sampling and restricted to known antigens. To address this, we collected pancreatic draining lymph nodes (pLN), "irrelevant" nonpancreatic draining lymph nodes, peripheral blood mononuclear cells (PBMC), and splenocytes from T1D subjects ( = 18) and control donors ( = 9) as well as pancreatic islets from 1 T1D patient; from these tissues, we collected purified CD4 conventional T cells (Tconv), CD4 Treg, CD8 T cells, and B cells. By conducting high-throughput immunosequencing of the TCR β chain () and B cell receptor (BCR) immunoglobulin heavy chain () on these samples, we sought to analyze the molecular signature of the lymphocyte populations within these tissues and of T1D. Ultimately, we observed a highly tissue-restricted CD4 repertoire, while up to 24% of CD8 clones were shared among tissues. We surveyed our data set for previously described proinsulin- and glutamic acid decarboxylase 65-reactive (GAD65-reactive) receptors, and interestingly, we observed a TRB with homology to a known GAD65-reactive TCR (clone GAD4.13) present in 7 T1D donors (38.9%), representing >25% of all productive TRB within Tconv isolated from the pLN of 1 T1D subject. These data demonstrate diverse receptor signatures at the nucleotide level and enriched autoreactive clones at the amino acid level, supporting the utility of coupling immunosequencing data with knowledge of characterized autoreactive receptors.
适应性免疫受体库在 1 型糖尿病 (T1D) 的发病机制中起着关键作用。然而,对 T1D 患者的 B 细胞和 T 细胞受体 (TCR) 谱进行特征描述的努力在很大程度上仅限于外周血采样,并且仅限于已知抗原。为了解决这个问题,我们从 T1D 患者 (= 18)和对照供体 (= 9)中收集胰腺引流淋巴结 (pLN)、“无关”非胰腺引流淋巴结、外周血单核细胞 (PBMC) 和脾细胞,以及来自 1 名 T1D 患者的胰腺胰岛; 从这些组织中,我们收集了纯化的 CD4 常规 T 细胞 (Tconv)、CD4 Treg、CD8 T 细胞和 B 细胞。通过对这些样本的 TCRβ链 () 和 B 细胞受体 (BCR) 免疫球蛋白重链 () 进行高通量免疫测序,我们试图分析这些组织内淋巴细胞群体以及 T1D 的分子特征。最终,我们观察到一个高度组织受限的 CD4 受体库,而多达 24%的 CD8 克隆在组织间共享。我们调查了我们的数据集中是否存在先前描述的胰岛素原和谷氨酸脱羧酶 65 反应性 (GAD65 反应性) 受体,有趣的是,我们观察到一个与已知 GAD65 反应性 TCR (克隆 GAD4.13) 具有同源性的 TRB,存在于 7 名 T1D 供体中 (38.9%),代表 1 名 T1D 患者 pLN 中分离的 Tconv 中所有有活性的 TRB 的 >25%。这些数据表明在核苷酸水平上存在不同的受体特征,并且在氨基酸水平上存在丰富的自身反应性克隆,支持将免疫测序数据与特征描述的自身反应性受体知识相结合的实用性。